Welcome to Micro Cap Gems, a weekly email newsletter dedicated to helping you find new stock ideas that are often missed by typical investment news sources. Each issue details an individual stock with unique potential and provides in-depth, independent analysis from the MicroCap Gems analyst staff.
To ensure you receive this e-mail in the future, please add support@mcgnewsletter1.messages1.com to your list of approved senders.
If you do not wish to receive such compelling stock ideas, simply go here to immediately remove your name from our mailing list.


IN THIS ISSUE
This Week's Gem
HealthStream, Inc.
-Outlook
-Summary Data

Gem Portfolio
-Portfolio Table
-Additions/Deletions

Updated Gems
GSI Technology Inc.
Norsat International Inc.
Sapiens International Corporation N.V.

Micro-Cap Market Overview

Micro Class Notes
-Scam Watch-
  "Green Energy Investment Scams"

About Us
-Mission Statement
-Editor Bio

Issuer Paid Research

Manage Your MicroCap Gems Subscription:
-Subscribe
-Unsubscribe

August 5, 2010  Volume 3, Issue 65

HEALTHSTREAM, INC.
(NASDAQ: HSTM) $4.57

OUTLOOK
HealthStream is a Nashville, Tennessee based provider of Internet-based learning and research solutions for the training, information, and education needs of the healthcare industry.

We find HealthStream attractive due to its strong and consistent revenue growth, the large market with mandatory training requirements in which its learning products compete, its high subscription and contract renewal rates and its improving balance sheet and margins.

Furthermore, from a technical analysis view point, we believe the stock may currently be attempting to build support just below the $4.50 area and again just below the $4.00 area. Therefore, should we be correct in our analysis and should these possible support areas continue to hold, levels near these possible support areas may offer long term investors an attractive entry opportunity.

HealthStream’s products and services fall into two segments, which include HealthStream Learning and HealthStream Research.

The Company's products help healthcare organizations meet ongoing training, education, information, and compliance needs.

HealthStream’s customer base across both its learning and research business units includes over 2,500 healthcare organizations, pharmaceutical and medical device companies.

CD AUCTIONS: BID FOR HIGHER YIELDS!

Certificate of Deposit Auctions from Zions Direct.

For more information, click HERE!

The Company's research products provide information about patients’ experiences, workforce challenges, physician relations, and community perceptions of services.

The Company’s learning products are used by healthcare organizations for a broad range of training and assessment needs.

It should be noted that HealthStream's learning products compete in a large market with mandatory training requirements.

There are over 5 million hospital-based healthcare professionals working in the nation’s approximately 5,000 acute-care hospitals. These professionals are required by federal mandates and accrediting bodies to complete training in a number of areas.

Furthermore, many healthcare professionals use continuing education to meet licensing, certification, and credentialing requirements as well as to keep up on the newest developments within the field.

The Company’s proprietary, Internet-based learning platform is its HealthStream Learning Center® platform.

As of December 31, 2009, the Company had approximately 1,974,000 fully implemented subscribers representing over 2,500 hospitals in the U.S. on its Internet-based HealthStream Learning Center platform.

It's important to note that during 2009, HealthStream renewed approximately 677,000 HealthStream Learning Center subscribers, representing a 102% renewal rate for the subscribers up for renewal, and a 103% renewal rate based on the annual contract value up for renewal.

What's more, during the year ended December 31, 2009, revenues from the Company's HealthStream Learning segment grew by $5.3 million or 16.2%.

Along these same lines, nearly 67% of the Company's 2009 revenues came from its learning segment.

During fiscal 2009 ending December 31, 2009, the Company reported total revenues of $57.398 million, an increase of over 11% compared to sales of $51.599 million in 2008.  Net income for fiscal 2009 was $13.972 million compared with $2.854 million in 2008.

It should be noted that net income includes an income tax benefit of approximately $9.1 million in 2009 and nearly $375,000 in 2008 associated with the recognition of a portion of the Company’s deferred tax assets. In both years the benefit was partially offset by a current income tax expense.

Furthermore, the Company recently updated its guidance and expects its consolidated revenues for the full year 2010 to increase by 11% to 13% over its 2009 results.

Additionally, HealthStream anticipates its operating income for the full year of 2010 will increase by 22% to 30% over its 2009 results.

More recently, for the three months ended June 30, 2010, revenues increased to $16.660 million from $14.584 million for the comparable period of 2009. Net income for the quarter ended June 30, 2010 was $1.348 million compared to $1.728 million for the same period of 2009.

It should be noted that the decrease in net income is mainly due to an income tax provision of approximately $995,000 in the second quarter of 2010 compared to $132,000 for the comparable quarter of 2009.

For the quarter ending June 30, 2010, the Company reported cash and equivalents of $18.809 million and working capital of $16.725 million. It should be mentioned that $11.583 million of accounts receivables make up a large portion of the short term assets in this working capital equation.

Furthermore, it should be noted that as of June 30, 2010, the Company had an un-utilized $15 million revolving credit facility loan agreement.

We believe the Company’s cash on hand, income from operations and borrowings under its line of credit are sufficient to cover any funding needed for operations in the foreseeable future.

Still, readers should be warned that failure by the Company to successfully obtain additional future funding if and when needed, may jeopardize its ability to continue its business and operations.

Also, readers should be cautioned of possible liquidity issues with the stock. There are 21.792 million shares outstanding and the float is approximately 15.17 million. Additionally, volume averages only approximately 28,700 shares per day. Keeping this in mind, when trading such thinly traded stocks, we strongly recommend the use of limit orders and warn readers to expect added volatility.

Furthermore, a significant amount of HealthStream's sales are subject to renewal each year.

For the year ended December 31, 2009, approximately 59% of the Company's net revenues were derived from its Internet-based subscription products.

Additionally, it should be noted that HealthStream depends on revenues from a small number of large customers. The loss of business from any one of its primary customers could have a material adverse effect on the Company.

Readers should also be aware that the Company faces strong competition from companies with larger customer basis, greater name recognition, and significantly more financial, technical, and marketing resources.

Also, investors should be aware there is no guarantee that the Company will be able to protect the intellectual property rights which its business relies upon.

Still, we believe the large market and mandatory training requirements in which the Company's learning products compete as well as its high subscription and contract renewal rates will allow HealthStream to continue its strong revenue growth. Additionally, the Company's improving balance sheet and small amount of long term debt should be advantageous as the Company meets growth challenges and attempts to maintain and manage that growth.

We believe HealthStream may offer high risk tolerant long term investors an attractive growth play in the micro-cap arena.

For more information on HealthStream, Inc., please visit the Company web site at www.healthstream.com. Additionally, information can be obtained from the Company's investor relations representative at (615) 301-3237 or through email at mollie.condra@healthstream.com.

Please see Summary Data and Income Statement below.

FREE Online Investing Seminar!

Learn how successful investors profit consistently – you'll learn:
* Why most investors fail – don't be part of this group!
* How to properly manage risk while maximizing profits
* When to be In and when to be Out of the market

For more information, click HERE!



Summary Data
52 wk high $5.53
Chart courtesy of StockCharts.com
52 wk low $1.98
One year return 15%
Average Daily Volume 28,700
Shares Outstanding (mil) 21.792
Market Capitalization ($mil) 103.7
Insider Ownership 35.1%
Annual Cash Dividend 0.0
Dividend Yield (%) 0.0
Risk level High
Industry

Internet Information Providers

INCOME STATEMENT
(Dollars In thousands, except per share amounts)
Full Year Ended December 31
2009
2008
Revenues
$57,398
$51,599

Total Operating Costs and Expenses

52,275
49,118
Income from Operations
5,122
2,481

Total Other Income (Expense)

(15)
72
Net Income before Taxes
5,107
2,553
Income Tax (benefit) Provision
(8,865)
(301)
Net Income
13,972
2,854
Basic earnings per share
$0.65
$0.13
Diluted earnings per share
$0.64
$0.13

AVERAGE ANALYST ESTIMATE
Full Year Ended December 31 2010 2011
Fiscal Yr $0.17 $0.22
^Single analyst Estimate.


COMPANY NAME
SYMBOL
INDUSTRY
DATE RECOMMENDED
PRICE ADDED
CURRENT PRICE
(8/4/10 Close)
RETURN PERCENTAGE
Air T Inc. AIRT Air Delivery & Freight Services
3/19/2008
$8.96
$8.66
-3.4%*
Computer Task Group, Inc. CTGX Information Technology Services
6/25/2008
$5.018
$7.78
55.0%
GSI Technology Inc. GSIT Semiconductor - Broad Line
10/29/2008
$3.30
$6.76
104.9%
HealthStream, Inc. HSTM Internet Information Providers
7/15/2009
$2.71
$4.57
68.6%
Jewett-Cameron Trading Company Ltd. JCTCF Lumber, Wood Production
7/23/2008
$6.75
$7.1399
5.8%
NAPCO Security Technologies, Inc. NSSC Security & Protection Services
12/3/2008
$1.41
$1.90
34.8%
Norsat International, Inc. NSATF Communications Equipment
4/7/2010
$0.77
$0.584
-24.2%
Sapiens International Corp. N.V. SPNS Technical & System Software
11/11/2009
$1.55
$2.98
92.3%
Servotronics, Inc. SVT Industrial Electrical Equipment
1/21/2010
$9.41
$9.01
-4.3%*
Taylor Devices, Inc. TAYD Diversified Machinery
6/30/2010
$5.26
$5.16
-1.9%

*Excludes dividends.
**Split adjusted price.


To see some of MicroCap Gems' past and present winners please click here.

The Holding Period Return for the MicroCap Gems portfolio year to date (12/31/2009 - 7/31/2010) is 19.48%.***

The Holding Period Return for the MicroCap Gems portfolio since inception (5/5/2005 - 7/31/2010) is 10.98%.***

The Russell Microcap Index year to date return (12/31/2009 - 7/31/2010) is 5.83%.
The Russell Microcap Index cumulative return for the period 5/5/2005 - 7/31/2010 is 0.09%.

***The portfolio is assumed to be equal weighted and is re-balanced every time there is an addition or deletion. Any dividends paid are incorporated into the holding period return. Data presented reflects past performance, which is no guarantee of future results. Due to market volatility, current performance may be higher or lower than the performance shown. Investors may incur a loss despite previous gains. Results will vary with economic and market conditions.

Additions/Deletions
There are no additions or deletions to the MicroCap Gem portfolio.


GSI Technology Inc.
(NASDAQ: GSIT) $6.76

The developer and marketer of static random access memory (SRAM) reported its twenty seventh consecutive quarter of profitability and record revenues and net income for its first quarter of fiscal 2011.

Revenues for the first quarter ended June 30, 2010, increased to $22.918 million from revenues of $21.244 million for the comparable quarter ended June 30, 2009. First quarter net income increased 15% to $4.379 million from $3.805 million for the three months ended June 30, 2009.

Furthermore, GSI's first quarter gross margin and operating margin increased year over year. The Company's gross margin for the first quarter of fiscal 2011 increased to 47.2% from 42.5% for the first quarter of fiscal 2010. GSI's operating margin during the first quarter of fiscal 2011 increased to 23.8% compared to 16.8% for the first quarter of fiscal 2010.

Additionally, the Company issued guidance for its second quarter of fiscal 2011. GSI anticipates net revenues for its second quarter of fiscal 2011 to be in the range of $23.9 million to $24.7 million and its gross margin to be approximately 45%.

Two analyst have revenue estimates out on GSI's second quarter with the low revenue estimate at $24.3 million and the high estimate at $24.4 million.

Currently, from a technical analysis view point, we believe the stock may see some resistance just above the $7.00 area. Still, a close above the $7.00 area on strong volume should be considered bullish.

Additionally, it appears as if the stock may be attempting to build support just below the $5.50 area. Therefore, should we be correct in our analysis and should this possible support area continue to hold, levels near this possible support area may offer long term investors an attractive entry opportunity.

We continue to find the Company attractive due to its strong balance sheet, its consistent profitability and its strong margins.

However, readers should be cautioned of possible liquidity issues with the stock. There are 27.739 million shares outstanding and the float is approximately 18.95 million. Additionally, volume averages only approximately 233,500 shares per day. Keeping this in mind, when trading such thinly traded stocks, we strongly recommend the use of limit orders and warn readers to expect added volatility.

Furthermore, readers should be aware that one customer accounts for a large percent of the Company's revenues. The loss of business from this or any one of its current customers could have a material adverse effect on GSI.

Over each of the past few fiscal years, Cisco Systems (CSCO) accounted for between 26% to 30% of the Company’s net revenue.

For more information on GSI Technology Inc., please visit the Company web site at www.gsitechnology.com.

Norsat International Inc.
(OTCBB: NSATF and TSX: NII) $0.584

The provider of broadband communication solutions announced financial results for the three months ended June 30, 2010.

Revenues for the second quarter ended June 30, 2010, increased 6.2% to $5.198 million from revenues of $4.896 million for the comparable quarter of 2009. The Company's second quarter net income increased to $827,690 from $238.337 for the three months ended June 30, 2009.

Furthermore, Norsat's second quarter gross margin increased slightly year over year. The Company's gross margin for the second quarter 2010 increased to 50.9% from 50.2% for the second quarter of fiscal 2009.

Additionally, the Company reported that during the second quarter ended June 30, 2010, it had repurchased 268,500 of its common shares at a weighted average share price of $0.68 (Cdn $0.69)
.

Currently, from a technical analysis view point, we believe the stock may be attempting to build support around the $0.50 area. Therefore, should we be correct in our analysis and should this possible support area continue to hold, levels near this possible support area may offer long term investors an attractive entry opportunity.

We find Norsat attractive due to its strong and consistent income and revenue growth, its expansion into new vertical markets, its strong balance sheet and lack of debt as well as the growing demand for broadband connectivity.

Still, readers should be cautioned of possible liquidity issues with the stock. There are only 53.590 million shares outstanding. Additionally, volume averages only approximately 27,700 shares per day. Keeping this in mind, when trading such thinly traded stocks, we strongly recommend the use of limit orders and warn readers to expect added volatility.

Additionally, the reader should be aware that the Company is listed on the OTC Bulletin Board quotation system and not on any of the major exchanges. The OTC BB system and the applicability of Penny Stock Rules could affect liquidity and/or market price.

It should also be noted that Norsat depends on revenues from a small number of large customers. The loss of business from any one of its primary customers could have a material adverse effect on the Company.

Furthermore, investors should be aware of possible technical obsolescence as more advanced products are developed that may compete against Norsat’s products.

Finally, readers should be cautioned that the Company faces strong competition from companies with larger customer basis, greater name recognition, and significantly more financial, technical, and marketing resources.

For more information on Norsat International Inc., please visit the Company web site at www.norsat.com. Additionally, information can be obtained from the Company's investor relations representative at (212) 370-4500 ext. 25 or through email at adam@wolfeaxelrod.com.

Sapiens International Corp. N.V.
(NASDAQ and TASE: SPNS) $2.98

The provider of information technology (IT) solutions for the insurance industry reported that one of the Company's subsidiaries received a claim submitted to the arbitration court in Warsaw, Poland.

The former Polish customer's claim of approximately EUR3.4 million, relates to a dispute regarding a project for the former customer from over two years ago.

Sapiens further stated that it is in the preliminary stage of reviewing the claim.

Currently, from a technical analysis view point, we believe the stock may see some resistance around the $3.25 area. Still, a close above the $3.25 area on strong volume should be considered bullish.

Additionally, it appears as if the stock may be attempting to build support just below the $2.00 area. Therefore, should we be correct in our analysis and should this possible support area continue to hold, levels near this possible support area may offer long term investors an attractive entry opportunity.

We continue to find the provider of information technology (IT) solutions for the insurance industry attractive due to its recent turn around and growth in its earnings, its strongly improved balance sheet, its increasing gross profits and decreasing operating expenses.

Still, readers should be warned that failure by the Company to successfully obtain additional future funding if and when needed, may jeopardize its ability to continue its business and operations.

It should also be noted that the Company depends on revenues from a small number of large customers. The loss of business from any one of its primary customers could have a material adverse effect on the Company.

Furthermore, the Company faces strong competition from U.S. and global companies with larger customer bases, greater name recognition, and significantly more financial resources and research and development facilities.

Additionally, the Company's international operations involve inherent risks, such as foreign currency fluctuations and compliance with various regulatory and tax regimes.

Similarly, the Company's corporate headquarters and research and development facilities are located in the State of Israel. Sapiens could be adversely affected by any major hostilities involving Israel as well as the interruption or curtailment of trade between Israel and its trading partners.

Finally, readers should be cautioned of possible liquidity issues with the stock. There are 21.591 million shares outstanding and the float is approximately 5.81 million. Additionally, volume averages only approximately 12,400 shares per day. Keeping this in mind, when trading such thinly traded stocks, we strongly recommend the use of limit orders and warn readers to expect added volatility.

For more information on Sapiens International Corp., please visit the Company web site at www.sapiens.com. Additionally, information can be obtained from the Company’s investor relations representative through the web site contact page at www.sapiens.com/contact.htm.



On Friday, July 30, 2010, the Russell Microcap® Index closed at 948.57. The index ended the week with the best performance of the four indexes for its year to date performance. However, the index also ended the week with the worst performance of the four indexes for its trailing 30 day period. The Russell Microcap Index was up 5.70% over the trailing 30 day period and up 5.83% year to date. The index was up 15.92% during the trailing twelve month period.

The Russell Midcap® Index ended the week with the best performance of the four indexes for its trailing 30 day and trailing 12 month periods. The index was up 7.19% over the trailing 30 day period and up 4.98% year to date. The Russell Midcap was up 23.21% during the trailing twelve month period.

The S&P 500 ended the week with the worst performance of the four indexes for its year to date and trailing 12 month periods. The Index was up 6.88% over the trailing 30 day period and down 1.21% year to date. The Index was up 11.64% during the trailing twelve month period.

The Dow Jones was up 7.08% over the trailing 30 day period and down 0.36% year to date. The Index was up 14.33% during the trailing twelve month period.

From a technical analysis point of view of the two major indexes, the S&P 500 may see some support just below the 1,000 area and some resistance just above the 1,150 area. The Dow may see support coming in just below the 9,000 level while resistance may be expected just above the 11,000 area.



In the Micro Class Notes section we share investing insight and strategies to keep you ahead of the market. Also in this section, we will alert you to scams and pump & dump operations, which will help you avoid land mines in the micro-cap world.
Scam Watch
"Green Energy Investment Scams"

The Financial Industry Regulatory Authority (FINRA) continues to warn investors to be on the lookout for green energy investment scams.

With all the negative news that has circulated around the Gulf Coast oil spill, a number of schemes have been popping up that promise unusually high returns through investments in green energy.

In these scams the fraudster attempts to create unwarranted demand for shares of a small, thinly traded company. The scammer then sells off their own shares, leaving investors with a worthless stock.

The con artists are using faxes, emails, text messages and even webinars and infomercials to lure unsuspecting investors into these pump and dump schemes.

Still, there are a number of measures investors can take to help protect themselves from these and other types of scams.

When you go to buy, use your eyes, not your ears.

-Czech Proverb

First of all, beware of any high-pressure sales tactics that include pushing you to act immediately or guaranteeing unusually high returns in comparison to other similar investment options. These ‘too good to be true’ opportunities may be warning signals.

Similarly, use caution if a solicitation claims that the investment is an exclusive opportunity available to only a handful of customers or normally reserved only for the wealthy.

Also, refuse any unsolicited contact from anyone seeking personal financial information or money.

Additionally, investors should use caution if the promoter claims the offered financial instrument is issued, traded, guaranteed, or endorsed by top banks.

Finally, make sure to do your homework. Carefully read any written material provided and check with your state securities regulator to establish if the investment is properly licensed and registered in your state.

Similarly, investors should ask the promoter if they or their firm is registered with FINRA (The Financial Industry Regulatory Authority), The SEC (U.S. Securities and Exchange Commission), or a state securities regulator, and if so, which one(s).

Investors should then take the time to verify the answers before investing any money. To check the background of an investment professional, investors can call the FINRA broker check toll-free at (800) 289-9999.

Additionally, investors can check with their state securities regulator by visiting the NASAA (North American Securities Administrators Association) web site or by calling (202) 737-0900.

Investors can also better protect themselves by seeking a professional, third-party opinion such as a financial advisor or broker. These individuals should be able to help you with understanding different investment instruments and the risks involved.

Mission
We know that micro-cap stocks can be risky but we believe that large profit potential exists in some of those same micro-cap companies.

The MicroCap Gems Newsletter attempts to find tremendous growth opportunities in the micro-cap market. We look for companies showing unusual promise and what we perceive as a favorable risk to reward ratio by using meticulous analysis of the company and its competitors. We do this by reading and evaluating all of the research reports written about micro-cap stocks, contacting the companies, customers and competitors.

Most of the research written about micro-cap stocks is termed “issuer paid research” since the companies themselves pay the research firm to have the report written.

MicroCap Gems is not an issuer paid research provider and to preserve our objective evaluations MicroCap Gems and its employees do not accept money, stock, services, or in-kind advertising in exchange for coverage of particular companies, securities or markets nor do any MicroCap Gem employees trade in any of the companies covered.

We believe that issuer paid research holds much value as long as you can filter out those reports making noise from the companies with true promise.

When we find a real ‘gem’ that merits your consideration we will profile the company in the MicroCap Gems newsletter. As many of these Gems are long-term investments, once we profile a company we will keep you abreast of on going developments as its investment story unfolds. As we do our due diligence we will also uncover and alert you to scams and pump/dump operations, which will help you avoid the land mines in the micro-cap world.

Editor Bio
The editor, Steven J. Anderson, has over 17 years experience in the investment and trading arena. He graduated from West Virginia University in 1992 with a BSBA in Finance/Investments and Securities. While in college, his stock market passion had him actively analyzing and speculating in small and micro-cap stocks by the time he started his junior year.

After college, Steve began trading commodity options and Dow futures as a member of the Chicago Board of Trade. However, his infatuation with smaller stocks soon had him starting up his own small cap investment newsletter. In 1996 he began writing the Anderson Small Cap Report that was an equities newsletter to investors focusing on small and micro capitalized stocks. Commentary from that newsletter was featured on many web sites and investment publications.

In 2004 Steve gave up trading to take a job as an Equity Analyst and ended the Anderson Small Cap Report.

Once again he found himself longing for the opportunity and excitement only found in the micro-cap stock arena. So in 2005 the MicroCap Gems newsletter was born.

Steve still believes that one of the most enjoyable aspects of writing his newsletter is his being permitted to help others benefit through his knowledge and experience. His infatuation with the markets and his desire to help others learn drives him to speak annually at the West Virginia University MBA Executive Speaker Series. At these seminars Steve speaks to students and industry professionals about his insight and involvement within the intriguing world of trading and investing.

The MicroCap Gems recommended stock portfolio is found in the "Gem Portfolio" section above the Updated Gems" section and below the "This Weeks Gem" section. Do not interpret any stock listed within this issuer paid research table as a recommendation by MicroCap Gems as no stock listed in this directory is to be construed as a recommendation by MicroCap Gems. The following directory is a compilation of companies with research reports or research updates provided within the past 12 months by the firm listed . MicroCap Gems does not endorse any views, opinions or recommendations contained in these reports or those of their editors, nor does MicroCap Gems guarantee the accuracy of the information within this directory. The table is for informational purposes only. Companies listed may or may not have paid for the research to be provided by the firm listed. MicroCap Gems in no way endorses the accuracy, completeness, reliability or timeliness of any information provided within these reports nor to the accuracy, completeness, reliability or timeliness of the table itself. The information contained in this directory is subject to change without notice. The table is solely for information purposes only and should not be construed as an offer or solicitation to purchase or sell any security listed. Past returns are no guarantee of future performance.

PLEASE CLICK HERE FOR TABLE
Issuerpaidtable


Disclaimer

The MicroCap Gems newsletter is solely for information purposes only and the statements and opinions in this report should not be construed as an offer or solicitation to purchase or sell any security. The information is created without regard to any investor's individual needs. If the reader should purchase or sell any security they do so at their own risk. MicroCap Gems LLC and its employees accept no liability for any losses or for consequential or incidental damages arising from any investor's reliance on or use of this report, even if the information is untimely, incomplete or incorrect. The reader should be aware the information provided by the editor may not be accurate, timely or complete. The information expressed in this letter is based upon the interpretation of available data, which the editor considers reliable, but the editor does not represent that the data is accurate or complete. The majority of statements and expressions are the sole opinions of the editor and are subject to change without notice. The data and information presented is provided for informational purposes only, and is not offered as a basis for investing in securities. Users of this letter should conduct their own independent investigation before making any investment or business decisions with respect to securities covered by the editor. MicroCap Gems LLC and its employees do not accept money, stock, services, or in-kind advertising in exchange for coverage of particular companies, securities or markets nor do any MicroCap Gems LLC employees trade in any of the companies covered. Past performance is no guarantee of future results. Investors may incur a loss despite a past history of gains. Any companies mentioned in this report may, or may not, be experiencing liquidity issues and may require additional capital to continue operations.

MicroCap Gems, LLC.
2020 North California Ave.
Suite 7 Number 125
Chicago, IL 60647
support@microcapgems.com

Subscribe

This resource is being sent by MicroCap Gems to our subscribers. We look to share investment resources with our customers that you may choose to use in making your own investment decisions. The resources are not intended to be personalized investment advice. MicroCap Gems is providing information on this resource to you subject to the MicroCap Gems privacy policy and disclaimer that can be viewed at http://microcapgems.com/privacy.html.

Want to unsubscribe? Then follow the instructions below. But note that if you choose to unsubscribe, then you will no longer receive any of the profit-producing offers from MicroCap Gems. So, this one may not have met your needs, but the next one might be just what you are looking for. Please keep that in mind before taking further action.

Here again, if you would prefer to not receive future messages from MicroCap Gems, then please click on the following link and confirm your request. Click Here.

To contact us by mail:

MicroCap Gems LLC
2020 North California Ave.
Suite 7 Number 125
Chicago, IL 60639